Webinar Update for Civil Society and Partners on pregnancy and the use of dolutegravir
On 18 May 2018 WHO issued a statement on potential safety issue affecting women living with HIV using dolutegravir at the time of conception. Since then WHO headquarters, regional and country offices have been actively working with countries and partners, including civil society, to explore policy and implementation implications
>> Більше